Santa Farma Continues Its Climb in İSO 500 List

Santa Farma, one of Türkiye's established pharmaceutical companies, once again ranked among Türkiye's largest industrial enterprises this year, according to the results of the "Türkiye's Top 500 Industrial Enterprises Survey" announced by the Istanbul Chamber of Industry (İSO). The company rose 15 places compared to last year to reach 439th place, once again demonstrating its production capacity, R&D investments and sustainable growth performance.
Santa Farma, one of the foundational companies in Turkey's pharmaceutical sector, has been included among Turkey's largest industrial enterprises according to the "Turkey's 500 Largest Industrial Enterprises Survey" announced by the Istanbul Chamber of Industry (İSO). The company rose 15 positions compared to the previous year to rank 439th, once again demonstrating its production capacity, R&D investments and sustainable growth performance.
Operating with over 80 years of experience, Santa Farma continues to rank among the strong players in Turkey's pharmaceutical industry through its high value-added production approach, technology investments and qualified human resources.
15-position rise
According to the 2025 results announced within the scope of the "Turkey's 500 Largest Industrial Enterprises Survey" prepared annually by the Istanbul Chamber of Industry based on various economic indicators including production and sales, Santa Farma rose to 439th position. The company's 15-position advancement compared to the previous year was an important indicator of its sustainable growth strategy and production-focused approach.
"We continue to create value for Turkey"
Santa Farma CEO Sami Kiresepi made the following comments regarding the success achieved:
"We are delighted to be included in the İSO 500 list prepared by the Istanbul Chamber of Industry this year and to continue our advancement compared to the previous year. This success is a natural consequence of our long-term investments in R&D, technology, production and human resources. With our domestic production capacity, high employment and world-standard production infrastructure, we not only contribute to Turkey's pharmaceutical needs, but also strengthen our presence in international markets with each passing day. In the coming period, we will continue to create value for both our country's economy and public health by increasing our production capacity, exports and value-added investments. I thank all our colleagues and business partners who contributed to this success."

Production capacity extending to over 65 countries
Founded in 1944, Santa Farma currently operates in 10 different therapeutic areas ranging from dermatology to cardiology, from respiratory system treatments to infectious diseases, with 56 brands and 127 products.
Operating through a production facility located in Kocaeli GEBKİM Organized Industrial Zone and holding EU-Good Manufacturing Practice (EU-GMP) certification, the company has an annual production capacity of 150 million boxes in 44,000 square meters of enclosed space.
Exporting to over 65 countries, Santa Farma continues to contribute to both the competitiveness of Turkey's pharmaceutical industry and its growth in global markets through its strong R&D infrastructure, production facilities meeting international quality standards and innovative product development initiatives.
Gallery








